234 related articles for article (PubMed ID: 25788426)
21. Restoration of renal responsiveness to atrial natriuretic peptide in experimental nephrotic syndrome by albumin infusion.
Abassi Z; Weissman I; Karram T; Goltsman I; Hoffman A; Better OS; Winaver J
Am J Nephrol; 2013; 38(4):292-9. PubMed ID: 24080549
[TBL] [Abstract][Full Text] [Related]
22. Serum- and glucocorticoid-inducible kinase 1 in doxorubicin-induced nephrotic syndrome.
Artunc F; Nasir O; Amann K; Boini KM; Häring HU; Risler T; Lang F
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1624-34. PubMed ID: 18768591
[TBL] [Abstract][Full Text] [Related]
23. Pefloxacin in adriamycin induced nephrotic syndrome in the rat.
Korzets Z; Pomeranz A; Golan E; Bernheim J
Nephrol Dial Transplant; 1997 Feb; 12(2):286-8. PubMed ID: 9132646
[TBL] [Abstract][Full Text] [Related]
24. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
Vaziri ND; Liang KH
Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
[TBL] [Abstract][Full Text] [Related]
25. [The effect of pefloxacin on nephrotic syndrome in experimental adriamycin nephropathy].
Zima T; Tesar V; Rychlík I; Nĕmecek K; Poledne R; Stejskalová A; Tĕmínová J; Stípek S; Merta M
Cas Lek Cesk; 1995 Oct; 134(20):658-60. PubMed ID: 7489582
[TBL] [Abstract][Full Text] [Related]
26. Pseudoductules in the rat liver in experimental adriamycin-induced nephrotic syndrome.
Pedrycz A; Wieczorski M; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):154-60. PubMed ID: 12898918
[TBL] [Abstract][Full Text] [Related]
27. Comparison of methods of inducing experimental nephrotic syndrome in lab animals.
Pedrycz A; Wieczorski M; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):116-20. PubMed ID: 15323177
[TBL] [Abstract][Full Text] [Related]
28. Regulation of epithelial sodium channel in puromycin aminonucleoside-induced unilateral experimental nephrotic syndrome in normal and analbuminemic Nagase rats.
Yu Z; Schumacher M; Frey BM; Frey FJ; Vogt B
Nephron Physiol; 2005; 101(3):p51-62. PubMed ID: 16020936
[TBL] [Abstract][Full Text] [Related]
29. Impaired glomerular and tubular antioxidative defense mechanisms in nephrotic syndrome.
Granqvist A; Nilsson UA; Ebefors K; Haraldsson B; Nyström J
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F898-904. PubMed ID: 20685819
[TBL] [Abstract][Full Text] [Related]
30. Uncovering the mechanism of Astragali Radix against nephrotic syndrome by intergrating lipidomics and network pharmacology.
Li AP; Yang L; Cui T; Zhang LC; Liu YT; Yan Y; Li K; Qin XM
Phytomedicine; 2020 Oct; 77():153274. PubMed ID: 32771537
[TBL] [Abstract][Full Text] [Related]
31. Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis.
Ulu N; Buikema H; van Gilst WH; Navis G
Nephrol Dial Transplant; 2008 Jun; 23(6):1854-60. PubMed ID: 18218687
[TBL] [Abstract][Full Text] [Related]
32. IL-1-like production in adriamycin-induced nephrotic syndrome in the rat.
Bricio T; Molina A; Egido J; Gonzalez E; Mampaso F
Clin Exp Immunol; 1992 Jan; 87(1):117-21. PubMed ID: 1733626
[TBL] [Abstract][Full Text] [Related]
33. The influence of pefloxacine on experimental adriamycin-induced nephrotic syndrome in rats.
Zima T; Tesar V; Rychlík I; Nĕmecek K; Poledne R; Tĕmínová J; Stípek S; Merta M
Ren Fail; 1996 Mar; 18(2):195-9. PubMed ID: 8723357
[TBL] [Abstract][Full Text] [Related]
34. Messenger RNA expressions of vasopressin system and aquaporin-2 in adriamycin-induced nephrotic rats and effects of astragalus membranaceus.
Ma J; Fan S; Chen J; Gu Y; Lin S
Chin Med J (Engl); 1999 Dec; 112(12):1068-72. PubMed ID: 11721440
[TBL] [Abstract][Full Text] [Related]
35. Baicalin attenuates adriamycin-induced nephrotic syndrome by regulating fibrosis procession and inflammatory reaction.
Tan N; Sun CX; Zhu HJ; Li DY; Huang SG; He SD
Genes Genomics; 2021 Sep; 43(9):1011-1021. PubMed ID: 34129194
[TBL] [Abstract][Full Text] [Related]
36. Changes of glomerular fixed anionic charge sites in adriamycin nephrosis in rats.
Wang Z; Wang ZG; Liu Z
Chin Med J (Engl); 1991 Feb; 104(2):128-31. PubMed ID: 1714805
[TBL] [Abstract][Full Text] [Related]
37. [The effect of lovastatin on the development of adriamycin nephropathy in rats].
Tesar V; Zima T; Poledne R; Stejskalová A; Tĕmínová J; Stípek S
Sb Lek; 1995; 96(1):35-42. PubMed ID: 8711364
[TBL] [Abstract][Full Text] [Related]
38. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
[TBL] [Abstract][Full Text] [Related]
39. Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats.
Medeiros M; Pérez-Urizar J; Pedraza-Chaverri J; Muñoz-Arizpe R; Castañeda-Hernández G
Can J Physiol Pharmacol; 2007 May; 85(5):502-6. PubMed ID: 17632584
[TBL] [Abstract][Full Text] [Related]
40. Overall condition improvement in a rat model of nephrotic syndrome treated with CellCept nanoliposomes.
Teng J; Zang L; Li L; Qiu X; Liu Y; Sun F
Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):128-134. PubMed ID: 26906101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
